New diabetes clinical trial: Research Study to Look at How Well Cagrilintide Together With Semaglutide Works in People With Type 2 Diabetes

Published on: July 29, 2021 at 09:30PM
Condition:   Diabetes Mellitus, Type 2
Interventions:   Drug: Semaglutide 2.4 mg;   Drug: Cagrilintide 2.4 mg;   Drug: Placebo (semaglutide);   Drug: Placebo (cagrilintide)
Sponsor:   Novo Nordisk A/S
Not yet recruiting
https://ift.tt/3rGGuuN

Comments

Popular posts from this blog